Pharmalogical, Inc. has developed the little pink pill for the treatment and prevention of fibroadenoma: Fibrosolve. Fibrosolve has launched today, Nov. 16, 2009.
New York, NY (1888PressRelease) November 17, 2009 - Liam Scully, President of Pharmalogical, Inc. announced that Fibrosolve, an all-natural supplement for the treatment and prevention of fibroadenomas*, will launch today, Nov. 16, 2009. Fibrosolve, "the little pink pill," will have a major impact on breast health and awareness, providing women with a noninvasive, risk-free treatment option for fibroadenomas.
"Fibrosolve is crucially important for breast health," says Mr. Scully. "Until now, women have not had a preventative option for fibroadenoma, or a natural treatment plan. Now women have options beyond simply monitoring the lump or resorting to surgery, giving women a healthy, safe alternative."
Fibroadenomas, which can be detected through regular breast exams, are benign breast tumors made of glandular and fibrous breast tissue. According to the Gale Encyclopedia of Medicine fibroadenomas occur among 10 percent of the female population, as well as 20 percent of African-American women. Fibroadenomas are most common in women ages 15-30, and pregnant women. Fibroadenomas are not cancerous, but the presence of fibroadenomas can increase the risk of a breast cancer diagnosis later in life. Women with multiple or complex fibroadenomas are about twice as likely to be diagnosed with breast cancer than women without fibroadenomas. While there is obviously no safeguard against a breast cancer diagnosis, it is important for women to be aware of all of their options, as well as all the methods to avoid a diagnosis. Fibrosolve is the only way to reduce the risk and appearance of fibroadenomas without an invasive surgical procedure.*
Until now, there has been no preventative treatment for fibroadenoma. The only options for women have been watchful waiting or an invasive, surgical procedure to remove the fibroadenoma. Even beyond the risks of surgery and anasthesia, women with small busts have had to deal with the deformities or irregularities associated with multiple lumpectomies.
Fibrosolve is the only way for women to both reduce the size of existing fibroadenomas and prevent the growth of future ones. It represents a major step forward in the promotion and knowledge of breast health.
Fibrosolve is now available to consumers nationwide on the Pharmalogical, Inc. Web site. For more information on Fibrosolve or to cover its launch, please contact Madeleine Desmond at madeleine.desmond ( @ ) upspringpr dot com dot
ABOUT PHARMALOGICAL, INC.
Pharmalogical, Inc. is a Long Island-based wholesaler and distributor of medical products and devices that is committed to providing the best customer service with the highest standard of ethics. The company is a licensed distributer cosmetic products like Botox, Restylane and Surgiderm, in addition to the BiomarC Tissue Marker System, a radiology product. Pharmalogical, Inc. provides its customers with the fairest and most affordable prices by buying wholesale from overseas, and passing on the cost savings directly to the customer.
Pharmalogical, Inc. is located at 1010 Northern Boulevard, Great Neck, NY 11021. For sales, call (888) 868-6147, or email sales ( @ ) pharmalogicalinc dot com dot
For press inquiries, contacted Madeleine Desmond at madeleine.desmond ( @ ) upspringpr dot com dot
* This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Pharmalogical, Inc. has developed the little pink pill for the treatment and prevention of fibroadenoma: Fibrosolve. Fibrosolve has launched today, Nov. 16, 2009. 
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam